Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings

Epidemiology and Infection

Volumn 142, Issue 3, 2014, Pages 494-500

  Aldeyab, M A ^a,b   Scott, M G ^b   Kearney, M P ^b   Alahmadi, Y M ^a   Magee, F A ^b   Conlon, G ^a   McElnay, J C ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

Author keywords

Antibiotic stewardship; Fluoroquinolones; Interrupted time series; Methicillin resistant Staphylococcus aureus; Primary and secondary care

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC STEWARDSHIP; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; COMMUNITY ASSESSMENT; DRUG USE; ECOSYSTEM MONITORING; HEALTH PROGRAM; HOSPITAL; HOSPITAL POLICY; HUMAN; INCIDENCE; INTERVENTION STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; PROTOCOL COMPLIANCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SECONDARY HEALTH CARE; THERAPY DELAY; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TREND STUDY; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; COMMUNITY CARE; CONTROLLED STUDY; HEALTH CARE POLICY; HEALTH IMPACT ASSESSMENT; HIGH RISK POPULATION; NONHUMAN; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; CROSS INFECTION; DRUG UTILIZATION; NORTHERN IRELAND; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CLINDAMYCIN; CROSS INFECTION; DRUG UTILIZATION; FLUOROQUINOLONES; HUMANS; INCIDENCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NORTHERN IRELAND; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS;

EID: 84896460128     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813001374     Document Type: Article

References (30)

1. Lindsay JA, Holden MT. Staphylococcus aureus: superbug, super genome? Trends in Microbiology 2004; 12: 378-385.
2. Wilcox MH, Dave J. The cost of hospital-acquired infection and the value of infection control. Journal of Hospital Infection 2000; 45: 81-84.
3. Gould IM. The clinical significance of methicillinresistant Staphylococcus aureus. Journal of Hospital Infection 2005; 61: 277-282.
4. Deleo FR, et al. Community-associated meticillinresistant Staphylococcus aureus. Lancet 2010; 375: 1557-1568.
5. Coia JE, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. Journal of Hospital Infection 2006; 63 (Suppl. 1): S1-44.
6. Aldeyab MA, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. Journal of Antimicrobial Chemotherapy 2008; 62: 593-600.
7. Stefani S, Goglio A. Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance. International Journal of Infectious Diseases 2010; 14 (Suppl. 4): S19-22.
8. Byrne FM, Wilcox MH. MRSA prevention strategies and current guidelines. Injury 2011; 42 (Suppl. 5): S3-6.
9. Davey P, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database ofSystematicReviews 2005; Issue 4,Art.No.CD003543.
10. Dellit TH, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases 2007; 44: 159-177.
11. Aldeyab MA, et al. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infection Control and Hospital Epidemiology 2011; 32: 210-219.
12. Aldeyab MA, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. Journal of Antimicrobial Chemotherapy 2012; 67: 2988-2996.
13. Aldeyab MA, et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. British Journal of Clinical Pharmacology 2012; 74: 171-179.
14. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2012. Oslo, 2011.
15. Tobacman JK. Assessment of comorbidity: a review. Clinical Performance and Quality Health Care 1994; 2: 23-32.
16. Conlon G, et al. Improving and maintaining adherence with hospital antibiotic policies: a strategy for success. Journal of Hospital Infection 2011; 77: 88-89.
17. Wagner AK, et al. Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 2002; 27: 299-309.
18. Tacconelli E, et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and metaanalysis. Journal of Antimicrobial Chemotherapy 2008; 61: 26-38.
19. Vernaz N, et al. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. Journal of Antimicrobial Chemotherapy 2008; 62: 601-607.
20. Kaier K, et al. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infection Control and Hospital Epidemiology 2009; 30: 346-353.
21. Parienti JJ, et al. Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis. Journal of Hospital Infection 2011; 78: 118-122.
22. Lafaurie M, et al. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone- resistant Pseudomonas aeruginosa isolation rates: a 10 year study. Journal of Antimicrobial Chemotherapy 2012; 67: 1010-1015.
23. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerging Infectious Diseases 2002, 8: 347-354.
24. Hoiby N, et al. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 1997; 349: 167-169.
25. Costelloe C, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. British Medical Journal 2010; 340: c2096.
26. Costelloe C, et al. Effect of antibiotic prescribing in primary care on meticillin-resistant Staphylococcus aureus carriage in community-resident adults: a controlled observational study. International Journal of Antimicrobial Agents 2012; 39: 135-41.
27. Sroka S, Gastmeier P, Meyer E. Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature. Journal of Hospital Infection 2010; 74: 204-211.
28. Jarlier V, et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Archives of Internal Medicine 2010; 170: 552-559.
29. Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clinical Infectious Diseases 2005; 41: 77-82.
30. Muller A, et al. Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. Journal of Antimicrobial Chemotherapy 2006; 58: 878-881.